The FTSE is just about trading in positive territory and unlike other European gauges it managed to hold its ground despite a weak close on Wall Street and heightened trade tensions between the US and China. The London index is being propped up by natural resources companies, utilities and oil producers helped by a further rise in oil prices.
Dousing hopes that the latest frosting up in US-China trade relations will be resolved swiftly, Google (NASDAQ:GOOGL) suspended part of its business with Huawei after President Trump put the firm on a trade blacklist. Huawei has almost become a barometer of the state of the trade dispute because it touches on many of the sore points that the two sides were not able to agree on during the talks including China’s perceived disregard for privacy and forced transfer of technology.
Pound firms post-Brexit talks breakdown
The pound firmed 31 pips against the dollar and 23 against the euro signalling that the market is not overly concerned by the breakdown in the Brexit talks between the Prime Minister and the Labour party, possibly hoping for a better outcome than the potential Brexit options that were put on the table by the two sides.
Ryanair's (LON:RYA) warning hits airlines
EasyJet PLC (LON:EZJ), British Airways’ parent International Consolidated Airlines and Tui (LON:TUIT) shares took a hit after Ryanair’s results reminded investors of the difficulties facing the travel sector, including high oil prices eroding the airlines’ margins.
Brexit is also working its destructive magic on European airlines, already competing hard against one another in an overcrowded market. The Irish budget airline reported its weakest annual profit in four years and chief executive Michael O'Leary warned that results could become even worse later this year as the European aviation markets suffer from "attritional fare wars."
In the US it will be a bumper week for IPOs with three biotech companies due to come onto the market on Wednesday. All three cancer-focused companies Peloton Therapeutics (NASDAQ:PLTX), Ideaya Biosciences (NASDAQ:IDYA) and Bicycle Therapeutics (NASDAQ:BCYC) deal with different stages of cancer treatment and prevention.
Disclaimer: The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient.
Any references to historical price movements or levels is informational based on our analysis and we do not represent or warrant that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, the author does not guarantee its accuracy or completeness, nor does the author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.